MEDISTIM ASA (MEDI.OL) Stock Fundamental Analysis
OSL:MEDI - NO0010159684 - Common Stock
257 NOK
-2 (-0.77%)
MEDI gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 58 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making MEDI a very profitable company, without any liquidiy or solvency issues. MEDI is valued quite expensive, but it does show an excellent growth. With these ratings, MEDI could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year MEDI was profitable.
MEDI had a positive operating cash flow in the past year.
MEDI had positive earnings in each of the past 5 years.
MEDI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 24.51%, MEDI belongs to the top of the industry, outperforming 96.55% of the companies in the same industry.
MEDI has a better Return On Equity (34.17%) than 96.55% of its industry peers.
MEDI has a Return On Invested Capital of 32.05%. This is amongst the best in the industry. MEDI outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MEDI is significantly above the industry average of 8.86%.
The last Return On Invested Capital (32.05%) for MEDI is above the 3 year average (24.89%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.51% | ||
| ROE | 34.17% | ||
| ROIC | 32.05% |
ROA(3y)20.73%
ROA(5y)20.96%
ROE(3y)26.96%
ROE(5y)27.52%
ROIC(3y)24.89%
ROIC(5y)25.57%
1.3 Margins
MEDI has a better Profit Margin (20.67%) than 89.66% of its industry peers.
In the last couple of years the Profit Margin of MEDI has remained more or less at the same level.
Looking at the Operating Margin, with a value of 26.96%, MEDI belongs to the top of the industry, outperforming 91.38% of the companies in the same industry.
In the last couple of years the Operating Margin of MEDI has remained more or less at the same level.
Looking at the Gross Margin, with a value of 80.94%, MEDI belongs to the top of the industry, outperforming 93.10% of the companies in the same industry.
In the last couple of years the Gross Margin of MEDI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.96% | ||
| PM (TTM) | 20.67% | ||
| GM | 80.94% |
OM growth 3Y-5.05%
OM growth 5Y-1.15%
PM growth 3Y-4.63%
PM growth 5Y-0.92%
GM growth 3Y1.08%
GM growth 5Y0.46%
2. Health
2.1 Basic Checks
MEDI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
MEDI has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, MEDI has more shares outstanding
Compared to 1 year ago, MEDI has a worse debt to assets ratio.
2.2 Solvency
MEDI has a debt to FCF ratio of 0.14. This is a very positive value and a sign of high solvency as it would only need 0.14 years to pay back of all of its debts.
MEDI has a Debt to FCF ratio of 0.14. This is amongst the best in the industry. MEDI outperforms 94.83% of its industry peers.
MEDI has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MEDI (0.06) is better than 87.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.14 | ||
| Altman-Z | N/A |
ROIC/WACC3.77
WACC8.5%
2.3 Liquidity
A Current Ratio of 3.14 indicates that MEDI has no problem at all paying its short term obligations.
The Current ratio of MEDI (3.14) is better than 86.21% of its industry peers.
MEDI has a Quick Ratio of 1.73. This is a normal value and indicates that MEDI is financially healthy and should not expect problems in meeting its short term obligations.
MEDI has a Quick ratio of 1.73. This is in the better half of the industry: MEDI outperforms 75.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.14 | ||
| Quick Ratio | 1.73 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 25.76% over the past year.
MEDI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.96% yearly.
The Revenue has grown by 17.85% in the past year. This is quite good.
Measured over the past years, MEDI shows a quite strong growth in Revenue. The Revenue has been growing by 9.12% on average per year.
EPS 1Y (TTM)25.76%
EPS 3Y4.41%
EPS 5Y7.96%
EPS Q2Q%24.21%
Revenue 1Y (TTM)17.85%
Revenue growth 3Y9.6%
Revenue growth 5Y9.12%
Sales Q2Q%16.67%
3.2 Future
MEDI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.78% yearly.
Based on estimates for the next years, MEDI will show a quite strong growth in Revenue. The Revenue will grow by 11.00% on average per year.
EPS Next Y16.97%
EPS Next 2Y13.46%
EPS Next 3Y11.78%
EPS Next 5YN/A
Revenue Next Year17.55%
Revenue Next 2Y12.56%
Revenue Next 3Y11%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 35.84, which means the current valuation is very expensive for MEDI.
Compared to the rest of the industry, the Price/Earnings ratio of MEDI is on the same level as its industry peers.
MEDI's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.06.
Based on the Price/Forward Earnings ratio of 32.89, the valuation of MEDI can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MEDI is on the same level as its industry peers.
MEDI is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.69, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.84 | ||
| Fwd PE | 32.89 |
4.2 Price Multiples
MEDI's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MEDI indicates a somewhat cheap valuation: MEDI is cheaper than 70.69% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.97 | ||
| EV/EBITDA | 23.91 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of MEDI may justify a higher PE ratio.
PEG (NY)2.11
PEG (5Y)4.5
EPS Next 2Y13.46%
EPS Next 3Y11.78%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.32%, MEDI has a reasonable but not impressive dividend return.
MEDI's Dividend Yield is rather good when compared to the industry average which is at 2.16. MEDI pays more dividend than 86.21% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, MEDI has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.32% |
5.2 History
The dividend of MEDI is nicely growing with an annual growth rate of 14.87%!
Dividend Growth(5Y)14.87%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The dividend of MEDI is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DPN/A
EPS Next 2Y13.46%
EPS Next 3Y11.78%
OSL:MEDI (9/8/2025, 4:19:51 PM)
257
-2 (-0.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners57.37%
Inst Owner ChangeN/A
Ins Owners2.83%
Ins Owner ChangeN/A
Market Cap4.71B
Analysts82.5
Price Target260.1 (1.21%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.32% |
Yearly Dividend4.5
Dividend Growth(5Y)14.87%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.33%
PT rev (3m)20.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)21.47%
EPS NY rev (3m)21.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.84 | ||
| Fwd PE | 32.89 | ||
| P/S | 7.43 | ||
| P/FCF | 30.97 | ||
| P/OCF | 30.97 | ||
| P/B | 12.28 | ||
| P/tB | 12.28 | ||
| EV/EBITDA | 23.91 |
EPS(TTM)7.17
EY2.79%
EPS(NY)7.81
Fwd EY3.04%
FCF(TTM)8.3
FCFY3.23%
OCF(TTM)8.3
OCFY3.23%
SpS34.6
BVpS20.93
TBVpS20.93
PEG (NY)2.11
PEG (5Y)4.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.51% | ||
| ROE | 34.17% | ||
| ROCE | 41.59% | ||
| ROIC | 32.05% | ||
| ROICexc | 41.86% | ||
| ROICexgc | 41.86% | ||
| OM | 26.96% | ||
| PM (TTM) | 20.67% | ||
| GM | 80.94% | ||
| FCFM | 23.98% |
ROA(3y)20.73%
ROA(5y)20.96%
ROE(3y)26.96%
ROE(5y)27.52%
ROIC(3y)24.89%
ROIC(5y)25.57%
ROICexc(3y)39.99%
ROICexc(5y)39.99%
ROICexgc(3y)48.52%
ROICexgc(5y)48.01%
ROCE(3y)32.29%
ROCE(5y)33.19%
ROICexcg growth 3Y-6.52%
ROICexcg growth 5Y0.36%
ROICexc growth 3Y-8.47%
ROICexc growth 5Y0.04%
OM growth 3Y-5.05%
OM growth 5Y-1.15%
PM growth 3Y-4.63%
PM growth 5Y-0.92%
GM growth 3Y1.08%
GM growth 5Y0.46%
F-Score6
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.14 | ||
| Debt/EBITDA | 0.11 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 77.82% | ||
| Profit Quality | 116.05% | ||
| Current Ratio | 3.14 | ||
| Quick Ratio | 1.73 | ||
| Altman-Z | N/A |
F-Score6
WACC8.5%
ROIC/WACC3.77
Cap/Depr(3y)105.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.78%
Cap/Sales(5y)N/A
Profit Quality(3y)91.83%
Profit Quality(5y)103.03%
High Growth Momentum
Growth
EPS 1Y (TTM)25.76%
EPS 3Y4.41%
EPS 5Y7.96%
EPS Q2Q%24.21%
EPS Next Y16.97%
EPS Next 2Y13.46%
EPS Next 3Y11.78%
EPS Next 5YN/A
Revenue 1Y (TTM)17.85%
Revenue growth 3Y9.6%
Revenue growth 5Y9.12%
Sales Q2Q%16.67%
Revenue Next Year17.55%
Revenue Next 2Y12.56%
Revenue Next 3Y11%
Revenue Next 5YN/A
EBIT growth 1Y32.5%
EBIT growth 3Y4.07%
EBIT growth 5Y7.86%
EBIT Next Year10%
EBIT Next 3Y10.15%
EBIT Next 5YN/A
FCF growth 1Y59.35%
FCF growth 3Y-0.65%
FCF growth 5Y12.16%
OCF growth 1Y59.35%
OCF growth 3Y3.75%
OCF growth 5Y12.23%